Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(28 sites)

United States

Vanda Investigative Site, Phoenix, Arizona

Vanda Investigative Site, Tempe, Arizona

Vanda Investigative Site, Tucson, Arizona

Vanda Investigative Site, Chula Vista, California

Vanda Investigative Site, Dublin, California

Vanda Investigative Site, Valencia, California

Vanda Investigative Site, Walnut Creek, California

Vanda Investigative Site, Doral, Florida

Vanda Investigative Site, Fort Myers, Florida

Vanda Investigative Site, Columbus, Georgia

Vanda Investigative Site, Oak Brook, Illinois

Vanda Investigative Site, Tinley Park, Illinois

Vanda Investigative Site, El Dorado, Kansas

Vanda Investigative Site, Wichita, Kansas

Vanda Investigative Site, Lexington, Kentucky

Vanda Investigative Site, Hazelwood, Missouri

Vanda Investigative Site, Las Vegas, Nevada

Vanda Investigative Site, Mount Kisco, New York

Vanda Investigative Site, Rochester, New York

Vanda Investigative Site, Kinston, North Carolina

Vanda Investigative Site, Cincinnati, Ohio

Vanda Investigative Site, Norman, Oklahoma

Vanda Investigative Site, Oklahoma City, Oklahoma

Vanda Investigative Site, Charleston, South Carolina

Vanda Investigative Site, Carrollton, Texas

Vanda Investigative Site, Salt Lake City, Utah

Vanda Investigative Site, Burke, Virginia

Vanda Investigative Site, Norfolk, Virginia